Premier Alternatives

DEKA Biosciences

Germantown, MD · Founded 2019 · Privately Held (backing)

Operator of a biotechnology company intended to develop and deliver life-changing medicines for cancer and inflammatory diseases. DEKA Biosciences is based in Germantown, MD and was founded in 2019. It was valued at $36 million at its early-stage round in Feb 2023, the last priced event on record. It has raised $104 million across 2 recorded rounds; the latest was a $29.9 million early-stage round in Feb 2023.

PMV mark · valuation
$36.0M
Oct 2026
Priced at
its early-stage round
Feb 2023
Total raised
$104.2M
Last round
Early Stage VC
Feb 2023

DEKA Biosciences key facts

as of Oct 2026
  • Operator of a biotechnology company intended to develop and deliver life-changing medicines for cancer and inflammatory diseases.
  • DEKA Biosciences is valued at approximately $36.0M as of Oct 2026, set at its early-stage round, Feb 2023; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $104.2M across 2 recorded rounds; the latest was Early Stage VC ($29.9M) in Feb 2023.
  • Notable investors include Alexandria Venture Investments, Echo Investment Capital, Viva BioInnovator, MPM BioImpact, ATEM Capital — 10 tracked in total.
  • DEKA Biosciences has filed 2 Form Ds with the SEC since 2021, most recently Dec 2023 ($29.9M sold to 33 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$36.0M

Valued at $36.0M at its early-stage round, Feb 2023. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of DEKA Biosciences with a free account
  • ·Watch DEKA Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

DEKA Biosciences funding rounds

2 rounds
Feb 2023Early Stage VC$29.9MSEC filing▮
Oct 2021Early Stage VC$15.9MSEC filing▮
Full funding history →

DEKA Biosciences valuation

DEKA Biosciences was valued at $36 million at its early-stage round in Feb 2023. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has DEKA Biosciences raised?

DEKA Biosciences has raised $104 million in total; 2 of its rounds are on record. The largest on record was a $29.9 million early-stage round in Feb 2023.

DEKA Biosciences has filed 2 Form Ds with the SEC since 2021, most recently in Dec 2023 ($29.9 million sold to 33 investors).

DEKA Biosciences investors

10 investors are on record for DEKA Biosciences, including Alexandria Venture Investments, Echo Investment Capital, Viva BioInnovator and MPM BioImpact. The early-stage round in Feb 2023 drew 33 investors.

About DEKA Biosciences

Operator of a biotechnology company intended to develop and deliver life-changing medicines for cancer and inflammatory diseases. The company's therapies have disease-specific applications that maximize patient benefits through improved pharmacokinetics/pharmacodynamics (PK/PD) function via targeted delivery of dual and complementary cytokines to affected tissues or cells, enabling patients with curative treatment options for cancer, autoimmune and infectious diseases.

Sector
Healthcare
HQ
Germantown, MD, United States
Founded
2019
Employees
20
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.